| Date | 15th-17th March, 2019 |
|---|---|
| Venue | TMC, Mumbai |
Dear Colleagues,
It is our pleasure to invite you for the 1st Immuno-Oncology Society of India Congress 2019 (I-OSICON2019), from 15th-17th March, 2019 at Tata Memorial Centre (TMC) Mumbai, India the leading tertiary cancer treatment and research centre in South Asia, one of the largest in the world.
Immuno-Oncology is a rapidly developing field of cancer and causing a paradigm shift in our approach to intractable issues in oncology hitherto. India and the surrounding regions carry a disproportionately large burden of global cancer patients with a fraction of the resources. The emerging promise of immunotherapy will find wide applicability from development to end-use stages.
I-OSICON 2019 will focus on the latest developments and findings in Immuno-Oncology including available treatments, as well as those in the development stage. The congress will welcome all disciplines of Oncology, Immunology, Researchers, Industry leaders, Regulators and Subject-experts.
With the introduction of this congress in Asia region we intend to provide an international platform for discussion of present and future challenges in Immunology education. National and international experts will present cutting-edge and practical clinical techniques based upon widely accepted evidence and will introduce new and emerging research.
This gathering incorporates plenary lectures, keynote speakers, poster/oral presentations, young researcher sessions, symposiums, workshops and exhibitions. It will focus on a wide array of topics including Emerging Immunotherapies, Engineered and Non-engineered Cellular therapies, Evidence-Based Immunotherapy for the Practitioner, Potential Immunological targets, Immune checkpoint inhibitors, Immune Responses and Adverse Events, Response evaluation in Immunotherapy, Precision Genomics and Precision Medicine for Immuno-Oncology, Technological developments of Immuno-Oncology, CAR T-cell production and Regulatory challenges in Immuno-therapies.
Notably, the conference proceedings and abstracts will be published in the “Journal of Immunotherapy & Precision Oncology “.
We are inviting leading internationally acclaimed researchers, basic scientists and clinicians as faculty and expect a gathering large number of attendees. Your participation will be of great encouragement to us and will also add lot of value to the congress in achieving its educational objectives.
To Register: https://in.eregnow.com/ticketing/register/I-OSI19
For more details visit our website: www.immunooncologyindia.com
Kindly block your dates.
Looking forward to welcoming you for this exciting congress.
Dr. Jyoti Bajpai
Organizing Secretary
1st Immuno-Oncology Society of India Congress 2019 (I-OSICON2019)
General secretary, Immuno Oncology Society of India
Professor of Medical Oncology
(Bone and soft Tissues,Breast,Gynec-Oncology)
Tata Memorial Centre, Mumbai
